Zhejiang Orient Gene Biotech (SHA:688298), along with two of its subsidiaries, obtained a number of international and domestic medical device registration certificates for their devices, according to a Friday disclosure on the Shanghai bourse.
The domestic certificates were handed to three devices, which are test kits for hepatitis C virus, helicobacter pylori and bordetella pertussis nucleic acid.
The international certificates were handed down to six devices, while U.S. Clinical Laboratory Improvement Amendments certificates were handed down to two test kits under the Healgen brand.